Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience

被引:0
|
作者
Oscar Epis
Cinzia Casu
Laura Belloli
Emanuela Schito
Davide Filippini
Marina Muscarà
Eleonora Bruschi
机构
[1] Niguarda Ca’ Granda Hospital,Rheumatology Unit
来源
Rheumatology International | 2015年 / 35卷
关键词
Rheumatoid Arthritis; Rheumatoid Arthritis Patient; Clinical Remission; Tocilizumab; Disease Remission;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1569 / 1570
页数:1
相关论文
共 50 条
  • [31] Associations of genetic polymorphisms with clinical response to tocilizumab in Chinese rheumatoid arthritis patients
    Qin, Wen
    Wang, Meng-Qiao
    Wang, Ting-Hui
    Xiao, Dong-Mei
    Wu, Xiu-Di
    Cen, Han
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 146
  • [32] Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data
    Nakashima, Yasuharu
    Kondo, Masakazu
    Fukuda, Takaaki
    Harada, Hiroshi
    Horiuchi, Takahiko
    Ishinishi, Takashi
    Jojima, Hiroshi
    Kuroda, Koji
    Miyahara, Hisaaki
    Maekawa, Masayuki
    Nishizaka, Hiroaki
    Nagamine, Ryuji
    Nakashima, Hitoshi
    Otsuka, Takeshi
    Shono, Eisuke
    Suematsu, Eiichi
    Shimauchi, Takashi
    Tsuru, Tomomi
    Wada, Ken
    Yoshizawa, Shigeru
    Yoshizawa, Seiji
    Iwamoto, Yukihide
    MODERN RHEUMATOLOGY, 2014, 24 (02) : 258 - 264
  • [33] Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission
    Nawata, Masao
    Saito, Kazuyoshi
    Nakayamada, Shingo
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2008, 18 (05) : 460 - 464
  • [34] Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis
    Frey, Nicolas
    Grange, Susan
    Woodworth, Thasia
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (07): : 754 - 766
  • [35] The impact of tocilizumab on anxiety and depression in patients with rheumatoid arthritis
    Tiosano, Shmuel
    Yavne, Yarden
    Watad, Abdulla
    Langevitz, Pnina
    Lidar, Merav
    Feld, Joy
    Tishler, Moshe
    Aamar, Suhail
    Elkayam, Ori
    Balbir-Gurman, Alexandra
    Molad, Yair
    Ehrlich, Sharon
    Abu-Shakra, Mahmoud
    Amital, Daniela
    Amital, Howard
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2020, 50 (09)
  • [36] Risk of infections in rheumatoid arthritis patients treated with tocilizumab
    Lang, Veronika R.
    Englbrecht, Matthias
    Rech, Juergen
    Nuesslein, Hubert
    Manger, Karin
    Schuch, Florian
    Tony, Hans-Peter
    Fleck, Martin
    Manger, Bernhard
    Schett, Georg
    Zwerina, Jochen
    RHEUMATOLOGY, 2012, 51 (05) : 852 - 857
  • [37] Efficacy and safety of tocilizumab in elderly patients with rheumatoid arthritis
    Pers, Yves-Marie
    Schaub, Roxane
    Constant, Elodie
    Lambert, Joseph
    Godfrin-Valnet, Marie
    Fortunet, Clementine
    Bourichi, Waafa
    Prades, Beatrice Pallot
    Wendling, Daniel
    Gaudin, Philippe
    Jorgensen, Christian
    Maillefert, Jean-Francis
    Marotte, Hubert
    JOINT BONE SPINE, 2015, 82 (01) : 25 - 30
  • [38] Analysis of effectiveness, safety and optimization of tocilizumab in a cohort of patients with rheumatoid arthritis in clinical practice
    Mena-Vazquez, Natalia
    Manrique-Arija, Sara
    Rojas-Gimenez, Marta
    Urena-Garnica, Inmaculada
    Jimenez-Nunez, Francisco G.
    Fernandez-Nebro, Antonio
    REUMATOLOGIA CLINICA, 2019, 15 (01): : 21 - 26
  • [39] Clinical outcome in patients with rheumatoid arthritis switched to tocilizumab after etanercept or infliximab failure
    Wakabayashi, Hiroki
    Hasegawa, Masahiro
    Nishioka, Yosuke
    Minami, Yukari
    Nishioka, Kusuki
    Sudo, Akihiro
    CLINICAL RHEUMATOLOGY, 2013, 32 (02) : 253 - 259
  • [40] Clinical and ultrasound evaluation of the response to tocilizumab treatment in patients with rheumatoid arthritis: a case series
    Epis, Oscar
    Filippucci, Emilio
    Delle Sedie, Andrea
    De Matthaeis, Anna
    Bruschi, Eleonora
    RHEUMATOLOGY INTERNATIONAL, 2014, 34 (05) : 737 - 742